Pancreatic Islet Cell Tumors - 25 Studies Found
Terminated |
: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors :
: 2007-01-29 :
|
Terminated |
: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET : Islet Cell Tumor : 2011-06-14 :
|
Completed |
: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors :
: 2008-01-25 :
|
Completed |
: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma :
: 2005-06-07 :
|
Withdrawn |
: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors :
:
|
Completed |
: Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization :
: 2007-02-09 :
|
Completed |
: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors :
: 2001-06-06 : Drug: bortezomib |
Recruiting |
: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders :
|
Recruiting |
: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors :
: Drug: PVA microporous hydrospheres/doxorubicin hydrochloride |
Completed |
: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors :
: |